PBS: FDA approves first biosimilar drug for distribution in the U.S.
PBS: FDA approves first biosimilar drug for distribution in the U.S
By Triana Kalmanoff
March 8, 2015
The Food and Drug Administration has approved the first biosimilar drug for distribution in the United States, the agency announced on Friday.
The drug approved was Zarxio, a medication used to prevent infections in cancer patients receiving chemotherapy.
The approval of the first biosimilar, which are copy-cat “generic” versions of brand-name biologic drugs, comes five years after the Affordable Care Act was signed into law in 2010 by President Barack Obama.
Biologics are a type of drug made from living cells, which makes them more complex and expensive than traditional pills that are made from mixing chemicals.
Read the full article at PBS Newshour.